awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47104104-2EB25FB9-0FA6-4663-84CD-2ABC4E7E6603
Q47104104-2EB25FB9-0FA6-4663-84CD-2ABC4E7E6603
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47104104-2EB25FB9-0FA6-4663-84CD-2ABC4E7E6603
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer.
P2860
Q47104104-2EB25FB9-0FA6-4663-84CD-2ABC4E7E6603
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47104104-2EB25FB9-0FA6-4663-84CD-2ABC4E7E6603
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6fe2592efb423f1b5debe08f7e328171b67cd7cc
P2860
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.